Indeed, as an inflammatory factor, YKL-40 secretion is mediated by proinflammatory cytokines in many types of cells (29), and its expression is significantly reduced after interferon therapy in patients with HCV-associated liver disease (30). Here, CHI3L1 is linked to liver disorder.